Characterization of tau in cerebrospinal fluid using mass spectrometry

Journal of Proteome Research

Volumn 7, Issue 5, 2008, Pages 2114-2120

  Portelius, Erik ^a   Hansson, Sara F ^a   Tran, Ai Jun ^a   Zetterberg, Henrik ^a   Grognet, Pierre ^a   Vanmechelen, Eugeen ^b   Höglund, Kina ^c   Brinkmalm, Gunnar ^a   Westman Brinkmalm, Ann ^a   Nordhoff, Eckhard ^d   Blennow, Kaj ^a   Gobom, Johan ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b INNOGENETICS   (Belgium)

^c ASTRAZENECA R AND D   (Sweden)

^d MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

Alzheimer's disease; Cerebrospinal fluid; Immunoprecipitation; LC MS MS; MALDI TOF MS; Tau

Indexed keywords

TAU PROTEIN; ISOPROTEIN; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; HUMAN; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; NANOFLOW LIQUID CHROMATOGRAPHY; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TANDEM MASS SPECTROMETRY; TAUOPATHY; AMINO ACID SEQUENCE; BRAIN LEVEL; CEREBROSPINAL FLUID; CHEMISTRY; GENETICS; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MOLECULAR GENETICS;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; BRAIN CHEMISTRY; CHROMATOGRAPHY, LIQUID; HUMANS; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN ISOFORMS; TAU PROTEINS;

EID: 52049096219     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr7008669     Document Type: Article

References (22)

1. Blennow, K.; de Leon, M. J.; Zetterberg, H. Alzheimer's disease. Lancet 2006, 368 (9533), 387-403.
2. Lindwall, G.; Cole, R. D. The purification of tau protein and the occurrence of two phosphorylation states of tau in brain. J. Biol. Chem. 1984, 259, 12241-12245.
3. Kosik, K. S.; Joachim, C. L.; Selkoe, D. J. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 1986, 83 (11), 4044-4048.
4. Nukina, N.; Ihara, Y. One of the antigenic determinants of paired helical filaments is related to tau protein. J. Biochem. (Tokyo) 1986, 99 (5), 1541-1544.
5. Wood, J. G.; Mirra, S. S.; Pollock, N. J.; Binder, L. I. Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau). Proc. Natl. Acad. Sci. U.S.A 1986, 83 (11), 4040-4043.
6. Ballatore, C; Lee, V. M.; Trojanowski, J. Q. Tau-mediated neuro-degeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci. 2007, 8 (9), 663-672.
7. Hernandez, F.; Avila, J. Tauopathies. Cell. Mol. Life Sci. 2007, 64 (17), 2219-2233.
8. Hanger, D. P.; Byers, H. L.; Wray, S.; Leung, K. Y.; Saxton, M. J.; Seereeram, A.; Reynolds, C. H.; Ward, M. A.; Anderton, B. H. Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. J. Biol. Chem. 2007, 282 (32), 23645-23654.
9. Blennow, K.; Hampel, H. CSF markers for incipient Alzheimer's disease. Lancet Neurol. 2003, 2 (10), 605-613.
10. Sjogren, M.; Vanderstichele, H.; Agren, H.; Zachrisson, O.; Eds-bagge, M.; Wikkelso, C; Skoog, I.; Wallin, A.; Wahlund, L.-O.; Marcusson, I.; Nagga, K.; Andreasen, N.; Davidsson, P.; Van- mechelen, E.; Blennow, K. Tau and A-beta42 in Cerebrospinal Fluid from Healthy Adults 21-93 Years of Age: Establishment of Reference Values. Clin. Chem. 2001, 47(10), 1776-1781.
11. Blennow, K.; Johansson, A.; Zetterberg, H. Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease. Int. J. Mol. Med. 2005, 26(6), 1147-1149.
12. Hesse, C; Rosengren, L.; Andreasen, N.; Davidsson, P.; Vanderstichele, H.; Vanmechelen, E.; Blennow, K. Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke. Neurosci. Lett. 2001, 297 (3), 187-190.
13. Zetterberg, H.; Hietala, M. A.; Jonsson, M.; Andreasen, N.; Styrud, E.; Karlsson, I.; Edman, A.; Popa, C; Rasulzada, A.; Wahlund, L. O.; Mehta, P. D.; Rosengren, L.; Blennow, K.; Wallin, A. Neurochemical aftermath of amateur boxing. Arch. Neurol. 2006, 63 (9), 1277-1280.
14. Hampel, H.; Buerger, K.; Zinkowski, R.; Teipel, S. ].; Goernitz, A.; Andreasen, N.; Sjoegren, M.; DeBernardis, J.; Kerkman, D.; Ishig- uro, K.; Ohno, H.; Vanmechelen, E.; Vanderstichele, H.; McCulloch, C; Moller, H. J.; Davies, P.; Blennow, K. Measurement of phos- phorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study. Arch. Gen. Psychiatry 2004, 61 (1), 95-102.
15. Sjogren, M.; Davidsson, P.; Tullberg, M.; Minthon, L.; Wallin, A.; Wikkelso, C; Granerus, A. K.; Vanderstichele, H.; Vanmechelen, E.; Blennow, K. Both total and phosphorylated tau are increased in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2001, 70 (5), 624-630.
16. Vanmechelen, E.; Vanderstichele, H.; Davidsson, P.; Van Ker- schaver, E.; Van Der Perre, B.; Sjogren, M.; Andreasen, N.; Blennow, K. Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phospho- peptide for standardization. Neurosci. Lett. 2000, 285 (1), 49-52.
17. Hansson, O.; Zetterberg, H.; Buchhave, P.; Londos, E.; Blennow, K.; Minthon, L. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol. 2006, 5 (3), 228-234.
18. Zetterberg, H.; Wahlund, L.O.; Blennow, K. Cerebrospinal fluid markers for prediction of Alzheimer's disease. Neurosci. Lett. 2003, 352 (1), 67-69.
19. Portelius, E.; Tran, A. J.; Andreasson, U.; Persson, R.; Brinkmalm, G.; Zetterberg, H.; Blennow, K.; Westman-Brinkmalm, A. Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry. J. Proteome Res. 2007, 6 (11), 4433-4439.
20. Mirgorodskaya, E.; Braeuer, C; Fucini, P.; Lehrach, H.; Gobom, J. Nanoflow liquid chromatography coupled to matrix-assisted laser desorption/ionization mass spectrometry: sample preparation, data analysis, and application to the analysis of complex peptide mixtures. Proteomics 2005, 5 (2), 399-408.
21. Gobom, J.; Schuerenberg, M.; Mueller, M.; Theiss, D.; Lehrach, H.; Nordhoff, E. Alpha-cyano-4-hydroxycinnamic acid affinity sample preparation. A protocol for MALDI-MS peptide analysis in proteomics. Anal. Chem. 2001, 73 (3), 434-438.
22. Blennow, K.; Wallin, A.; Agren, H.; Spenger, C; Siegfried, 1.; Vanmechelen, E. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease. Mol. Chem. Neuropathol. 1995, 26 (3), 231-245.